Clinical Trials
162 trialsDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
City of Hope Medical Center
TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea
Vanderbilt-Ingram Cancer Center
MITHRIDATE
University of Birmingham
Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
Ohio State University Comprehensive Cancer Center
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
ENERGIA
University of Turin, Italy
Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm
M.D. Anderson Cancer Center
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
University of Southern California
AVAJAK
University Hospital, Brest
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
University of Washington
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
M.D. Anderson Cancer Center
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
University of California, Irvine
A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV
Peking Union Medical College Hospital
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
City of Hope Medical Center
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
MPN Research Foundation
WELL-MPN
Brigham and Women's Hospital
ACTIVAQ
Hospices Civils de Lyon
Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis
M.D. Anderson Cancer Center
Ruxolitinib in Thrombocythemia and Polycythemia Vera
Massachusetts General Hospital
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
University of Miami
Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
M.D. Anderson Cancer Center
Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
CONT-LOW-PV
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
ET2PV
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
TREATMORE
Icahn School of Medicine at Mount Sinai
POLYVISCO
Hospices Civils de Lyon
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
Thomas Jefferson University
Two Step Haplo With Radiation Conditioning
Thomas Jefferson University
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
UNC Lineberger Comprehensive Cancer Center
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Barbara Ann Karmanos Cancer Institute
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Roswell Park Cancer Institute
Registry of Older Patients With Cancer
UNC Lineberger Comprehensive Cancer Center
Ruxo-BEAT
RWTH Aachen University
Ruxolitinib and Lenalidomide for Patients With Myelofibrosis
M.D. Anderson Cancer Center
Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms
IRCCS Azienda Ospedaliero-Universitaria di Bologna
EVEREST
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Efficacy and Safety of Peginterferon in ET and PV.
Tongji Hospital
Pegasys® in Patients With Myeloproliferative Diseases
M.D. Anderson Cancer Center
Low-PV
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Myeloproliferative Neoplasms (MPNs) Patient Registry
University Health Network, Toronto
OBENE
University Hospital, Brest
PV-ARC
IRCCS Azienda Ospedaliero-Universitaria di Bologna
PV
Institute of Hematology & Blood Diseases Hospital, China
AIRPORT-MPN
Ottawa Hospital Research Institute
REVIEW
Gruppo Italiano Malattie EMatologiche dell'Adulto
Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
Fox Chase Cancer Center
Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms
Federico II University
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
City of Hope Medical Center
MOSAICC
Queen's University, Belfast